Teleflex (TFX) Research & Development (2009 - 2026)
Teleflex's (TFX) quarterly Research & Development came in at $45.1 million in Q2 2026, up 70.35% on a YoY basis from $26.5 million in Q2 2025, and up 1.66% quarter-over-quarter from $44.4 million in Q1 2026.
Analysis
Teleflex (TFX) Research & Development (2009 - 2026) Analysis & Trends
Teleflex (TFX) has reported Research & Development for 18 consecutive years, with $45.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Research & Development rose 70.35% year-over-year to $45.1 million; the trailing twelve-month figure through Jun 2026 stood at $159.4 million (up 93.38% YoY), and the FY2025 full-year result was $144.8 million, up 32.8% from the prior year.
- Research & Development climbed to $45.1 million in Q2 2026 per TFX's latest filing, from $44.4 million in the prior quarter.
- Across five years, Research & Development topped out at $57.2 million in Q3 2025 and bottomed at -$8.1 million in Q4 2024.
- Historically, Research & Development has averaged $32.6 million across 5 years, with a median of $37.7 million in 2022.
- The sharpest annual moves came in 2023 and 2025: Research & Development tumbled 111.38% in 2023, then soared 255.94% in 2025.
- Over 5 years, Research & Development stood at $42.8 million in 2022, then sank by 111.38% to -$4.9 million in 2023, then plunged by 66.42% to -$8.1 million in 2024, then jumped by 255.94% to $12.6 million in 2025, then soared by 257.32% to $45.1 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $45.1 million, $44.4 million, and $12.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.08 Bn | 174.48 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Intuitive Surgical | 127.86 Bn | 122.64 Bn | 1.96 Bn | 370.60 Mn |
| 3 | Medtronic | 117.15 Bn | 108.33 Bn | 6.34 Bn | 771.00 Mn |
| 4 | Stryker | 103.82 Bn | 100.34 Bn | 4.50 Bn | 434.00 Mn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 554.00 Mn |
| 6 | Edwards Lifesciences | 49.76 Bn | 45.51 Bn | 1.35 Bn | 278.90 Mn |
| 7 | Alcon | 32.95 Bn | 31.49 Bn | 1.68 Bn | -663.00 Mn |
| 8 | Dexcom | 32.22 Bn | 30.27 Bn | 830.00 Mn | 153.00 Mn |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Teleflex | 5.73 Bn | 5.43 Bn | 331.71 Mn | 45.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 45.12 Mn |
| Mar 31, 2026 | 44.39 Mn |
| Dec 31, 2025 | 12.63 Mn |
| Sep 28, 2025 | 57.23 Mn |
| Jun 29, 2025 | 26.49 Mn |
| Mar 30, 2025 | 25.30 Mn |
| Dec 31, 2024 | -8.10 Mn |
| Sep 29, 2024 | 38.73 Mn |
| Jun 30, 2024 | 41.09 Mn |
| Mar 31, 2024 | 37.30 Mn |
| Dec 31, 2023 | -4.87 Mn |
| Oct 1, 2023 | 37.58 Mn |
| Jul 2, 2023 | 39.45 Mn |
| Apr 2, 2023 | 41.47 Mn |
| Dec 31, 2022 | 42.76 Mn |
| Sep 25, 2022 | 37.77 Mn |
| Jun 26, 2022 | 36.93 Mn |
| Mar 27, 2022 | 36.36 Mn |
| Dec 31, 2021 | 35.80 Mn |
| Sep 26, 2021 | 31.82 Mn |